A Noble Pursuit: Gene Therapy for Rare Disease
Rare disease, as the name suggests, affects a small proportion of the population and appears with low prevalence. The limited number of ...
Developing Therapeutics That Teach the Body to Heal Itself
Future Watch: Gene & Cell Therapy
A Revolution In Medicine And Healthcare Blog
Future Watch: Gene & Cell Therapy
A Revolution In Medicine And Healthcare Blog
- All
- Biotech Investment
- Cell Therapy
- Cell Therapy Investing
- Disease
- Gene Therapy
- Gene Therapy Investing
- HIV
- HIV Cure
- HIV History
- HIV/AIDS Research
- Innovation & Business
- People Changing Lives
- Rare Disease Research
- Scientific Breakthroughs
- Women's History Month
How to Design a Gene Therapy to Target Viruses
This is a lesson you won't learn in school. We're at an exciting stage in biotechnology today, on the cusp of revolutionizing ...
Transaction Trends 2022: A Good Time to be a Private Company
[1] Contributing Author John Vandermosten, Senior Biotechnology Analyst After a final burst of initial public offerings (IPOs) in early 2021, times have been ...
Jeff Galvin Wins Life Sciences Voice Top Industry Leaders Award
Contributing Author: Kathy Fowler American Gene Technologies® CEO and founder Jeff Galvin was awarded the Life Sciences Voice 2023 Top Industry Leaders ...
HIV Has Been Cured For a 5th Time, Now Researchers Are Developing Scalable Methods
Contributing Author Luke Williams, Sales and Marketing A mounting body of evidence shows that HIV, once thought to be an incurable lifelong ...
The Future is Written by Female Scientists – In Genetic Code
Contributing Author Luke Williams, Sales and Marketing Our world has been revolutionized by biotechnologies like CRISPR-based gene editing and mRNA vaccines. This ...
Raising Awareness for Rare Disease Day
Contributing Author Luke Williams, Sales and Marketing Each year on February 28th we shine a spotlight on rare disease research. There are ...
How to Design a Gene Therapy to Target Inherited Diseases
Contributing Author Luke Williams, Sales and Marketing The human genome contains approximately 20,000 protein-coding genes. When read, these genes tell a cell ...
Black Pioneers in Biology Who Ushered Us Into the Genetic Age
Contributing Author Luke Williams, Sales and Marketing Meet the scientists who revolutionized our understanding of biochemistry and reframed the human identity For ...
The Biotech Project Podcast Dives into the Passionate Vision of Jeff Galvin
Contributing Author: Kathy Fowler The Biotech Project podcast hosts Scott J Resnik, MBA, NYS EMT-CC, and John Walsh, MD, sit down with ...
American Gene Technologies Celebrates Another Year of Progress
Contributing Author John Vandermosten, Senior Biotechnology Analyst In 2022, the world was collectively compelled to endure a surge in viral outbreaks, the horror ...
Phase 1 HIV Clinical Trial Data Published in “Frontiers in Medicine” Journal
Contributing Author Luke Williams, Sales and Marketing American Gene Technologies® (AGT) designed AGT103-T in hopes of functionally curing HIV. The therapeutic is ...
Gene Therapy Clinical Trial Requirements
Contributing Author John Vandermosten, Senior Biotechnology Analyst Gene Therapy Does It "My Way" In 1990, gene therapy burst onto the world stage with ...
ShareTreck Host Interviews Jeff Galvin on The Future of Medicine
Contributing Author: Kathy Fowler Raj Natarajan, host of ShareTreck, goes behind the scenes with Jeff Galvin, Founder and CEO of American Gene™ ...
The Future of Gene Therapy
Contributing Author John Vandermosten, Senior Biotechnology Analyst Economies of scale can apply to gene therapy too Gene therapy's advantage is its ability to ...
Monkeypox: Separating Fact from Fiction
Contributing Author John Vandermosten, Senior Biotechnology Analyst With almost three years of COVID consuming our lives, a reprieve from viral outbreaks seemed deserved. ...
The FDA’s Evolving Approach to Drug Approval
Contributing Author John Vandermosten, Senior Biotechnology Analyst One hundred and fifty years ago, the world of medicine was radically different from today. The ...
2021 IPO & M&A Trends
Contributing Author John Vandermosten, Senior Biotechnology Analyst Transaction Trends 2021: Pandora's Box 2020 was a tremendous year for Initial Public Offerings (IPOs) where ...
Top Cell Therapy Approvals and Pipeline / Cell Therapy is More Than CAR T
Contributing Author John Vandermosten, Senior Biotechnology Analyst Cell therapy is the transfer of therapeutic cells to a patient. It replaces damaged cells or ...
FDA Gene Therapy Approvals
Contributing Author John Vandermosten, Senior Biotechnology Analyst Despite the impact of the pandemic and the seemingly solitary focus of the health care machine ...
Chapter IV: Solving The Riddle, A Consequential Approach
Contributing Author John Vandermosten, Senior Biotechnology Analyst The arc of HIV history has been developing over the last four decades. In the early ...
What Is CAR T-Cell Therapy? How It Works In 2-Minutes
Contributing Author : Gina Big Picture Cancer is a leading cause of death worldwide. In the U.S., only heart disease ranks above ...
What Is Stem Cell Therapy? How It Works In 2-Minutes
Contributing Author : Gina Big Picture Genomic medicine is bringing hope where none previously existed. This approach to cure and treat ...
What Is Gene Editing? How It Works In 2-Minutes
Contributing Author : Gina Big Picture Gene therapy, stem cell therapy, CAR T, cell therapy, and gene editing are all forms ...
Technology Transfer, A Catalyst For Gene Therapy Startups | The Spark Therapeutics Example
Contributing Author: Gina Hagler The ability to consistently bring treatments and cures to market depends upon a company's capacity to create ...
What Is Gene Therapy? How It Works In 2-Minutes
Contributing Author: Gina Hagler Big Picture Gene therapy, stem cell therapy, CAR-T, cell therapy and gene editing are all forms ...
Biotech IPOs 2020 and M&A Trends
Transaction Trends 2020 Life sciences transactions have boomed over the last year. Merger and acquisition (M&A) activity distinguished itself with ...
Rare Disease Moms Make Their Voices Heard | Three Inspirational Stories
Contributing Author: Gina Hagler There are 7,000 known rare diseases in the world. Each of them affects less than 1% of the ...
5 Ways Gene Therapy Companies are Transforming Rare Disease Cures
Contributing Author: Gina Hagler Historically, developing rare disease cures and treatments has been challenging. The small, globally dispersed patient population made it ...
A SPACtacular Way to Go Public
What Is A SPAC Anyway? 2020 turned out to be a fantastic year for private companies to go public. In a ...
3 Gene Therapy Companies Powering a Revolution in Rare Disease Cures
Contributing Author: Gina Hagler Gene therapy companies are powering a revolution in rare disease cures by offering treatments that target the genetic ...
5 Reasons Gene Therapy Companies are Vital to the Future of Biopharma
Contributing Author: Gina Hagler Pharmaceutical companies have been developing therapies to treat or prevent disease since the end of the 19th century. ...
5 Biotech Companies in Maryland That May Make History in 2021
Contributing Author: Gina Hagler These five biotechnology companies in Maryland may make history in 2021 because they have multiple therapeutic programs in ...
What Star Wars Can Teach Us About Cell Therapy Investments
Contributing Author: Gina Hagler It's difficult to believe there is anything that Star Wars can teach us about cell therapy, let alone ...
The Berlin Patient’s Success Produces A Flurry of Activity
The Berlin Patient's success provided optimism that there was a way to permanently disable HIV and eradicate it from an infected person. ...
7 Cell Therapy Companies in Maryland Helping to Revolutionize Drug Discovery: The Latest News
Contributing Author: Gina Hagler Maryland has one of the largest life science clusters in the United States with more than 500 biotech companies. ...
The Race for a COVID Vaccine Foreshadows a Medical Revolution
Contributing Author Luke Williams, Sales and Marketing Conventional vaccine development can take many years, yet vaccines targeting the novel coronavirus were approved ...
Rare Diseases: Why Are They Difficult to Cure?
Contributing Author: Gina Hagler Approximately 7,000 rare diseases affect 350-500 million people worldwide. The majority of these (80%) are monogenic, so-called because these ...
The History of HIV Cure Research: Reaching for a Cure
Contributing Author: Gina Hagler A new immune deficiency illness came on the scene in 1981. In the years immediately following, four questions arose ...
The History of HIV Cure Research: The Latest Research in BioPharma
Contributing Author: Gina Hagler In the forty years since the HIV/AIDS pandemic began in 1981, researchers have learned a lot about this disease ...
9 Reasons Treatment of Rare Diseases Will be Big in 2025
Of the 7,000 known rare diseases affecting 350 to 400 million people worldwide, most have a genetic basis and it often comes ...
Why Is It So Difficult to Find an HIV Cure?
More than 32 million people have died from AIDS-related illnesses since the start of the epidemic in 1981, making HIV/AIDS one of ...
ARC of HIV History 2 – A Beginning and an End
Contributing Author John Vandermosten, Senior Biotechnology Analyst This is the second installment of our series on the Arc of HIV History which examines ...
List of 88 Gene Therapies
Contributing Author Luke Williams, Sales and Marketing Biotechnology is a rapidly expanding sector where game-changing innovation is a daily occurrence. Gene and ...
In Memory of Timothy Ray Brown
Contributing Author : Jeff Galvin, CEO and Founder American Gene Technologies A Message From the CEO of American Gene Technologies® Timothy Ray ...
4 Global Trends That Will Affect HIV Cure Research in 2025
Contributing Author: Gina Hagler Researchers have been working on an HIV Cure since the first reports of the illness appeared in 1981. ...
The Arc of HIV History
Contributing Author John Vandermosten, Senior Biotechnology Analyst The Early Days When We Knew Nothing It is uncertain how the human immunodeficiency virus or ...
The History of HIV Cure Research: Discovery to Treatment
Contributing Author: Gina Hagler When reports of a new immune deficiency disease hit the news in the summer and fall of 1981, ...
Gene Therapy: More than Monogenic Disease
Contributing Author John Vandermosten, Senior Biotechnology Analyst Gene therapy is a diverse technology that can address a broad variety of diseases, conditions and ...
Treatment of Rare Diseases: What You Need to Know
Contributing writer: Gina Hagler What is a Rare Disease? The definition of a rare disease varies by country, with the consensus that ...
Rare Disease: One Mom’s Fight to Save Her Son, Amber Freed Raises Millions to Create a Cure. Coronavirus won’t stop her.
By Contributing Writer Gina Hagler There are nearly 7,000 rare diseases affecting approximately 1% of the global population. When your child is ...
Top 5 Harvard Business Review Must Reads That Will Shape the Future of Biotechnology
The Harvard Business Review (HBR) has provided thought-provoking content since 1922. Whether business leaders are interested in optimizing their organizational structure or ...
Top 5 TED Talks on Gene Technology that Every Biotech Leader Must Watch
TED Talks began in 1984 as a conference originating in Silicon Valley where powerful voices in Technology, Entertainment, and Design came together ...
The Death of the Regulatory Barrier to Better Medicine
Written by Jeff Galvin, CEO of American Gene Technologies® The birth of high-value therapeutics and cures Does the development of effective drugs have ...
What Impact Did the Stock Market Crash Have on Biotech Stocks?
Contributing Author John Vandermosten, Senior Biotechnology Analyst Examining events of the past can give us a sense of what to expect in the ...
Benefits of FDA Orphan Drug Designation: What You Need to Know
by Irene Tennant VP of Clinical Product Development and Regulatory Affairs Developing treatments for rare diseases has many challenges. These challenges are ...
12 Coronavirus Stocks To Watch As The Race For A Coronavirus Vaccine and Treatment Continues
Contributing Author John Vandermosten, Senior Biotechnology Analyst Over the last two months nothing has dominated the news as extensively as the coronavirus pandemic ...
Gene Therapy M&A: Best Prospects 2020
Contributing Author John Vandermosten, Senior Biotechnology Analyst As we enter the twelfth year of an economic expansion, deal activity remains one of ...
WHAT IS GENE THERAPY?
Contributing Author: Norman Rogers, Former Business Development Lead at AGT ™ Gene therapy is a tool to modify the composition and expression ...
Cell Therapy is Creating the Next Generation Cures for Cancers
Today Human immunity is a beautifully complex system. Students of science around the world groan at the mention of immunology because of ...
Can HIV Be Cured? History of HIV Treatment Moving Toward an HIV Cure
You don't have to look far to find someone affected by HIV. It is estimated 1.1 million Americans are infected with the ...
Is HIV Curable?
Is HIV Curable? American Gene Technologies® (AGT™) believes it is. Read why AGT's Chief Science Officer is committed to discovering a cure ...
Gene Therapy Companies in Maryland
Maryland is home to one of the largest life science clusters in the nation. According to the Maryland Department of Commerce, the ...
Gene Therapy Stocks 2019
Why has gene therapy become so significant within the last five years? While it is not well-known, the genes we are born ...
Business Innovation: 5 Disruptive Technology Leaders Tell You How To Develop Creativity and Innovation In The Workplace
American Gene Technologies® (AGT™) recently hosted a panel of thought leaders from five different industries at the Hot Technologies & Innovations event ...
Science Moms
At times mothers do not get enough credit. However, today, let's shine a light on the scientists who were raising children, at ...
Honoring Nurses On National Nurses Day
Today and this week are the times of year we honor nurses. On this National Nurses Day, we asked Caroline, a local ...
Scientific Discoveries That Changed Lives
There have been historic moments in scientific research that have gone unnoticed. Often we don’t hear about these scientific discoveries until they ...
Acquisition of Celgene – Medicine is Changing
On January 3rd, Bristol-Myers Squibb announced its agreement to acquire Celgene for approximately $74 billion. This merger is a sign of change ...
HIV Cure in the News
Today the world celebrated the second patient cured of HIV. The work of Ravindra Gupta teaches us lessons not only of the ...
Why Invest in an HIV Gene Therapy Cure?
Research and innovation to cure HIV is developing fast. American Gene Technologies® (AGT™) is emerging as a leader in the field with their ...
The Next Generation of Gene Therapy Companies
The future of medicine is bright. This year brought several first in class technologies over the finish line. The underpinning of these ...
The Gene Therapy Market is going to produce a Microsoft
The most common analogy used to compare the science of DNA to other industries is that of computer software. DNA can be ...
AGT™ Announces First-Ever Reddit AMA on the Potential of Gene Therapies
We are proud to have participated in our first-ever Reddit AMA on April 21, 2016. AGT CEO, Jeff Galvin and Chief Science ...
CEO Jeff Galvin Addresses Congress on the Biotechnology Investment Tax Credit
Jeff Galvin, CEO of American Gene Technologies® provided testimony in a Senate Hearing on March 8, 2016 in support of Maryland's Biotechnology ...
